Dr. Sidra Raza, MD

Dr. Raza practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Raza's NPI, 1306159744, was assigned on July 14, 2010. Dr. Raza holds Kansas license 04-36330.

Dr. Raza's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Raza's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Raza to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raza practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Raza's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Raza's licenses on file in 2 states: Kansas and Michigan.

CMS data shows 630 Medicare services from Dr. Raza across 6 procedure codes in 2024, for 169 Medicare patients. Medicare paid $50,854 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 169 Medicare patients who saw Dr. Raza in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raza's median patient age at 74, with 46% women.

In 2024, Dr. Raza wrote 346 Medicare Part D claims for 99 patients. 88% of them were for generic drugs. CMS names the drug for 71 of them, across 5 drugs with 11 or more claims each, at $468 in total drug cost. In 2023, CMS named 63 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Raza for performance year 2024, reported through an alternative payment model (APM). Dr. Raza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Dr. Raza from 3 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $137.